The Multidisciplinary Association for Psychedelic Studies (MAPS) is seeking contributions to their MDMA research capstone campaign to end Phase 3 trials for the treatment of PTSD. All donations over $100,000 are tax-deductible and individuals can donate by emailing [email protected] or visiting maps.org/capstone.